Pixantrone: a B-cell-depleting immunosuppressant for multiple sclerosis patients with active disease

Conclusion: These preliminary data indicate the efficacy of PIX in active RRMS and SPMS.

http://msj.sagepub.com/cgi/content/abstract/22/6/817?rss=1

Source: Multiple Sclerosis - April 17, 2016 Category: Neurology Authors: Gonsette, R., Debouverie, M., Sindic, C., Ferre, J.-C., Edan, G. Tags: Original Research Papers Source Type: research